Colitis: Diagnosis and Therapeutic Strategies

List of principal contributors. List of chairpersons. Preface.-
SECTION I: DIAGNOSIS. 1 Role of capsule encoscopy in Crohn's disease. 2 Endoscopy in Crohn's disease. 3 Colitis diagnosis and therapeutic strategies - how, what and when to biopsy.-
SECTION II: MICROSCOPIC COLITIS. 4 Epidemiology of microscopic colitis. 5 Microscopic colitis: histological classification. 6 Mechanisms of pathogenesis in microscopic colitis. 7 Microscopic colitis: treatment.-
SECTION III: PREDICTING OUTCOMES. 8 Predicting the natural history of inflammatory bowel disease. 9 Who gets extra-intestinal manifestations? 10 Colitis: predicting outcomes -- who gets cancer?.-
SECTION IV: CORTICOSTEROID THERAPY. 11 Mechanisms of steroid action and resistance in inflammatory bowel disease. 12 Budesonide for ulcerative colitis. 13 How do I use steroids in Crohn's disease? 14 Why corticosteroids should not be used as first-line therapy for Crohn's disease.-
SECTION V: AZATHIOPRINE. 15 Azathioprine: molecular mechanism of action. 16 Pharmacogenetics of azathioprine - useful in clinical practice? 17 Azathioprine: long-term side-effects. 18 State-of-the-Art Lecture: Trials and complications of ileal pouch surgery.-
SECTION VI: IMMUNOMODULATORY THERAPY. 19 Biologics in ulcerative colitis.-
SECTION VII: CANCER AND IBD. 20 Diagnosis of colitis associated dysplasia: new colonoscopic techniques. 21 Can we prevent cancer using current drugs? 22 Management of low-grade dysplasia in inflammatory bowel disease. 23 Low-grade dysplasia in flat mucosa: is it relevant?.-
SECTION VIII: NEW THERAPEUTIC APPROACHES. 24 Leucocytapheresis. 25 Helminths and immune.- modulation of inflammatory bowel disease. 26 Probiotics for inflammatory bowel disease.-
Index